Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The DNA–O2 complex, also known as the DNA peroxyl radical, is a critical chemical intermediate formed during the interaction of ionizing radiation with cellular DNA in the presence of molecular oxygen. According to the oxygen fixation hypothesis, radiation-induced DNA radicals react rapidly with oxygen to form these stable, non-restorable complexes, which "fix" the damage and prevent chemical repair by endogenous thiols like glutathione. This process significantly enhances the lethality of radiation, a phenomenon known as the oxygen effect, making oxygenated cells much more sensitive to radiotherapy than hypoxic ones. In clinical oncology, the DNA–O2 complex is a central target for radiosensitizers, which are drugs designed to mimic the action of oxygen in hypoxic tumor regions to promote the formation of these lethal lesions. Understanding the dynamics of this complex is essential for improving the efficacy of cancer treatments and overcoming the radioresistance associated with tumor hypoxia.
Oxygen fixation (reacting with radiation-induced DNA radicals to prevent chemical restoration and ensure permanent strand breaks)
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA–Oxygen complex (DNA–O2).